Detection of compounds that rescue Rab1-synuclein toxicity.

Methods Enzymol

FoldRx Pharmaceuticals, Inc., Cambridge, Massachusetts, USA.

Published: June 2008

Recent studies implicate a disruption in Rab-mediated protein trafficking as a possible contributing factor to neurodegeneration in Parkinson's disease (PD). Misfolding of the neuronal protein alpha-synuclein (asyn) is implicated in PD. Overexpression of asyn results in cell death in a wide variety of model systems, and in several organisms, including yeast, worms, flies, and rodent primary neurons, this toxicity is suppressed by the overproduction of Rab proteins. These and other findings suggest that asyn interferes with Rab function and provide new avenues for PD drug discovery. This chapter describes two assay formats that have been used successfully to identify small molecules that rescue asyn toxicity in yeast. The 96-well format monitors rescue by optical density and is suitable for screening thousands of compounds. A second format measures viable cells by reduction of the dye alamarBlue, a readout that is compatible with 96-, 384-, and 1536-well plates allowing the screening of large libraries (>100,000 compounds). A secondary assay to eliminate mechanistically undesirable hits is also described.

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0076-6879(07)00425-9DOI Listing

Publication Analysis

Top Keywords

detection compounds
4
compounds rescue
4
rescue rab1-synuclein
4
rab1-synuclein toxicity
4
toxicity studies
4
studies implicate
4
implicate disruption
4
disruption rab-mediated
4
rab-mediated protein
4
protein trafficking
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!